Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 286, Issue 16, Pages 13977-13984Publisher
AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M111.227884
Keywords
-
Categories
Funding
- Kempkes Stiftung [12/08]
- Deutsche Forschungsgemeinschaft [BA-1793/5-1, DE-1482/3-1, DE-1482/2-1]
- Wellcome Trust
Ask authors/readers for more resources
Two-pore domain potassium (K-2P) channels play a key role in setting the membrane potential of excitable cells. Despite their role as putative targets for drugs and general anesthetics, little is known about the structure and the drug binding site of K-2P channels. We describe A1899 as a potent and highly selective blocker of the K-2P channel TASK-1. As A1899 acts as an open-channel blocker and binds to residues forming the wall of the central cavity, the drug was used to further our understanding of the channel pore. Using alanine mutagenesis screens, we have identified residues in both pore loops, the M2 and M4 segments, and the halothane response element to form the drug binding site of TASK-1. Our experimental data were used to validate a K-2P open-pore homology model of TASK-1, providing structural insights for future rational design of drugs targeting K-2P channels.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available